Results 31 to 40 of about 23,362 (196)

Tailoring therapy for heart failure: the pharmacogenomics of adrenergic receptor signaling. [PDF]

open access: yes, 2014
Heart failure is one of the leading causes of mortality in Western countries, and β-blockers are a cornerstone of its treatment. However, the response to these drugs is variable among individuals, which might be explained, at least in part, by genetic ...
Barrese, V   +3 more
core   +2 more sources

Preoperative gabapentin versus bisoprolol for haemodynamic and surgical field optimisation during endoscopic sinus surgery: A randomised controlled trial

open access: yesIndian Journal of Anaesthesia, 2021
Background and Aims: Appropriate premedication can optimise haemodynamics and hence surgical field visibility during endoscopic sinus surgery (ESS). This study aimed to compare the intraoperative effect of gabapentin 1200 mg versus bisoprolol 2.5 mg ...
Abeer M Elnakera   +3 more
doaj   +1 more source

Cost-effectiveness of eplerenone in patients with systolic heart failure and mild symptoms [PDF]

open access: yes, 2014
Aim In the Eplerenone in Mild Patients Hospitalization and Survival Study in Heart Failure (EMPHASIS-HF), aldosterone blockade with eplerenone decreased mortality and hospitalisation in patients with mild symptoms (New York Heart Association class II ...
Akehurst, R.   +9 more
core   +3 more sources

Bisoprolol transdermal patch improves orthostatic hypotension in patients with chronic heart failure and hypertension

open access: yesClinical and Experimental Hypertension, 2020
β blockers (BBs) play an important role in heart failure (HF) treatment. However, orthostatic hypotension (OH) is sometimes caused by BBs. The bisoprolol transdermal patch works more slowly and is long acting compared with the bisoprolol fumarate tablet.
Shunsuke Kiuchi   +7 more
doaj   +1 more source

A krónikus szívelégtelenség epidemiológiája, a kezelési lehetőségek, a bisoprolol helye a terápiás palettán [PDF]

open access: yes, 2013
The prevalence of chronic heart failure in Hungary is 1.6% in the adult population, but it occurs in 15-20% of subjects over 80 years of age. The base of treatment of heart failure is the blockade of the neuro-hormonal system, which includes the use of ...
Nagy, Viktor
core   +1 more source

EFFICACY AND SAFETY OF IVABRADINE AND BISOPROLOL IN PATIENTS WITH ISCHEMIC HEART DISEASE: RESULTS OF COMPARATIVE RANDOMIZED OPEN STUDY

open access: yesРациональная фармакотерапия в кардиологии, 2016
Aim. To study influence of ivabradine as compared with bisoprolol on clinical and hemodynamic indices, exercise tolerance, endothelial function, quality of life (QL) and erectile function in patients with ischemic heart disease. Material and methods.
R. D. Kurbanov   +3 more
doaj   +1 more source

Hypertension - state of the art 2017 [PDF]

open access: yes, 2017
No abstract ...
McCallum, Linsay
core   +1 more source

EFFICACY AND SAFETY OF BISOPROLOL IN YOUNG MEN WITH ARTERIAL HYPERTENSION AND OBESITY

open access: yesРациональная фармакотерапия в кардиологии, 2016
Aim. To evaluate effect of bisoprolol on circadian blood pressure (BP) profile, autonomic cardiovascular regulation, lipid and carbohydrate metabolism in young patients with arterial hypertension (HT) and obesity. Materials and methods. 36 men aged 18 to
A. G. Avtandilov   +2 more
doaj   +1 more source

Replicated evidence for aminoacylase 3 and nephrin gene variations to predict antihypertensive drug responses [PDF]

open access: yes, 2017
Peer ...
Donner, Kati M.   +8 more
core   +1 more source

Home - About - Disclaimer - Privacy